Tobufar Bvba
⚠️ Moderate Risk
FEI: 3006260175 • Uccle, Brussels • BELGIUM
FEI Number
3006260175
Location
Uccle, Brussels
Country
BELGIUMAddress
Rue Joseph Bens 83a, , Uccle, Brussels, Belgium
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NO ENGLISH
Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
Frequently Asked Questions
What is Tobufar Bvba's FDA import refusal history?
Tobufar Bvba (FEI: 3006260175) has 1 FDA import refusal record(s) in our database, spanning from 1/5/2011 to 1/5/2011.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Tobufar Bvba's FEI number is 3006260175.
What types of violations has Tobufar Bvba received?
Tobufar Bvba has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Tobufar Bvba come from?
All FDA import refusal data for Tobufar Bvba is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.